Feature

Article

Pharmaceutical Executive

Pharmaceutical Executive: May 2024
Volume44
Issue 5

Pharmaceutical Executive: May 2024 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive May 2024 issue in an interactive PDF format.

May 2024
Download Issue PDF
Articles in this issue
Pharmaceutical Executive: May 2024 Issue (PDF)
Pharmaceutical Executive: May 2024 Issue (PDF)
'Patients are Waiting'
'Patients are Waiting'
Today’s New Messaging Mix: The State of Pharma Marketing in 2024
Today’s New Messaging Mix: The State of Pharma Marketing in 2024
Patient Treatment & Travel: The Need for Stepped-Up Support
Patient Treatment & Travel: The Need for Stepped-Up Support
A Biosimilars Roadmap: Understanding Payer Perceptions
A Biosimilars Roadmap: Understanding Payer Perceptions
Avoiding the Digital Age is Hurting Research Efforts
Avoiding the Digital Age is Hurting Research Efforts

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Pharmaceutical Executive
Peter Rubin
Related Content
President Donald Trump
September 30th 2025

Pfizer Announces Agreement with Trump Administration to Lower Prices, Join TrumpRx, and Avoid Tariffs

Mike Hollan
Pharmaceutical Executive
September 30th 2025

Pharmaceutical Executive Daily: September 29, 2025

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

FDA Grants Approval for Kedrion Biopharma’s Primary Humoral Immunodeficiency Treatment Qivigy

Nicholas Jacobus
Pharmaceutical Executive
September 30th 2025

Pharmaceutical Executive Daily: September 26, 2025

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

AstraZeneca Announces Plans to Harmonize Global Listing Structure for Stock Exchanges Alongside Positive Enhertu Updates

Mike Hollan
Stock.adobe.com
September 30th 2025

AbbVie Breaks Ground on Illinois API Manufacturing Site

Mike Hollan
© 2025 MJH Life Sciences

All rights reserved.